MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Out-licensing

A Method for Using Molecular Networks in Genetic Linkage Analysis of Complex Disorders

Columbia Technology Ventures
Lead Inventor: Andrey Rzhetsky STV Reference: IR 1750 and IR 1902 Problem or Unmet Need: One of the major practical goals of genetics is to find the genetic origin of diseases and to understand how genetic mutations may alter particular physiological...

Full description

Lead Inventor:

Andrey Rzhetsky STV Reference: IR 1750 and IR 1902 Problem or Unmet Need: One of the major practical goals of genetics is to find the genetic origin of diseases and to understand how genetic mutations may alter particular physiological properties in humans, animals and plants. Vast amounts of expensive data (financed both by the government of by the industry) in form of pedigrees and genotypic measurements have already been gathered.
The current methods were at best moderately successful in mapping the prevalent disorders (such as bipolar disorder, schizophrenia, and diabetes) with apparent polygenic inheritance. There is a pressing need for methods that can improve the understanding of the available data in order to use this information for effective search of novel pharmaceutical targets.

Details of the Invention:

The technology is a method that could significantly improve the currently used genetic analysis approaches by using the growing in size and quality knowledge about molecular function and molecular networks. The authors presented a set of statistical models for genetic linkage analysis, which explicitly use the functional relationships between loci (genes) represented in molecular networks or in other types of molecular function databases. The authors also created a set of effective computational tools, which can be practically applied for analyzing the data on numerous multi-factorial and polygenic disorders (like mental disorders, diabetes, asthma, etc.) Vast amounts of expensive data have already been gathered and the method can readily be applied to effectively extract more information from that data. In addition, the authors presented a novel class of descriptive models designed to be used for finding relationships between multiple genes contributing to complex disorders in humans.

Applications:

• The method can assist in understanding the genetic components of complex disorders and identify candidate genes for complex disorders in humans, which might lead to identifying new drugs, developing new diagnostic procedures, etc.

• The invention might be used for evaluation potential side effects of newly discovered drugs through analysis of drug target known molecular interactions.

• Additional possible applications include food design and food production. The goal is to understand the genetic mechanisms that affect agricultural plant / animal resistance to certain diseases and influence their nutritional value.

Advantages:

• The invention should dramatically increase the power of genetic analysis as applied to complex hereditary disorders.

• It integrates (within the same probabilistic model) molecular networks with the currently used genetic analysis techniques.

• Presented model also does not have limitations that were present in previously published genetic-linkage models.

Development status

Early Stage

Patent information

App. #: 60/787,711 60/788,794 60/788794 60/788,794

Patent pending (WO 2007/115095)

Type of business relationship sought

Licensing or sponsored research support

Licensing contact

Shai Gilad
Technology Licensing

Contact directly

Company details

Columbia Technology Ventures

Columbia Technology Ventures manages Columbia University’s intellectual property portfolio and serves as the University’s gateway for companies seeking novel technology solutions.

View profile

Related reports

Are you looking for reports related to this particular subject. Our Reports section is the best place to start.

Related items

Related categories

Industry sector
Diagnostic / Genetic diagnostics
Therapeutic target
Genetic disorders

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
BioPartnering America
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us